[CRISPR-Cas9 activation screening identifies candidate chemokine regulators of ter-tiary lymphoid structure formation in bladder cancer]. [PDF]
Wang Y, Song H, DU Y, Xu T.
europepmc +1 more source
[Advances in intravesical therapy for non<b>-</b>muscle<b>-</b>invasive bladder cancer]. [PDF]
Li J, Xue Y, Guo Z, Ye S, Ma Q, Jia X.
europepmc +1 more source
[Analysis of self-control trial results of narrow band imaging and white light in transurethral resection of bladder tumor]. [PDF]
Qiu M +9 more
europepmc +1 more source
[Expression characteristics and clinical significance of <i>ERBB2</i> in bladder urothelial carcinoma based on the TCGA database]. [PDF]
Zheng G, Peng Y, DU Y, Xu T.
europepmc +1 more source
[Development of a 36-gene signature for predicting recurrence in non-muscle-invasive bladder cancer and validation in a Chinese cohort]. [PDF]
Dong L +5 more
europepmc +1 more source
[Bladder cancer local staging about muscle invasion: 3.0T MRI performance following transurethral resection]. [PDF]
Zhao SM +7 more
europepmc +1 more source
[Conversion from Bricker to orthotopic neobladder: A case report]. [PDF]
Yang H +7 more
europepmc +1 more source
[Myricetin inhibits proliferation and migration of bladder cancer cells by inhibiting HSP90AA1-mediated AKT phosphorylation]. [PDF]
Sun R +5 more
europepmc +1 more source
[Risk factors of positive surgical margin and multifocal positive surgical margin after robot-assisted radical prostatectomy]. [PDF]
Wang K +10 more
europepmc +1 more source
[Comparison of preoperative nutritional scoring systems for predicting survival in upper tract urothelial carcinoma]. [PDF]
Guo Z, Sun C, Lai S, Gao H, DU Y, Xu T.
europepmc +1 more source

